We are live on ! Find out more
MLA

MB, Levis & Associates Portfolio holdings

AUM $271M
1-Year Est. Return 15.56%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+15.56%
3 Year Est. Return
+39.99%
5 Year Est. Return
10 Year Est. Return
AUM
$271M
AUM Growth
+$31.7M
Cap. Flow
+$15.6M
Cap. Flow %
5.75%
Top 10 Hldgs %
59.42%
Holding
266
New
32
Increased
93
Reduced
19
Closed
12

Top Sells

Rank Stock Value
1
IBDW icon
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
+$13.7M
2
CAT icon
Caterpillar
CAT
+$47.4K
3
HON icon
Honeywell
HON
+$46.6K
4
ABT icon
Abbott
ABT
+$33.7K
5
FDX icon
FedEx
FDX
+$25.1K

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.73%
2 Technology 5.51%
3 Industrials 5.27%
4 Healthcare 3.16%
5 Financials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGK icon
151
Vanguard FTSE Europe ETF
VGK
$30.8B
$17.3K 0.01%
196
+3
+2% +$263
IBTK icon
152
iShares iBonds Dec 2030 Term Treasury ETF
IBTK
$1.02B
$17.2K 0.01%
880
+8
+0.9% +$157
IWP icon
153
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
$16.4K 0.01%
112
LRCX icon
154
Lam Research
LRCX
$385B
$15.2K 0.01%
35
+10
+40% +$3.04K
DVN icon
155
Devon Energy
DVN
$52.9B
$14.7K 0.01%
356
+3
+0.8% +$139
C icon
156
Citigroup
C
$231B
$13.7K 0.01%
98
DIS icon
157
Walt Disney
DIS
$182B
$13.7K 0.01%
142
AIRR icon
158
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.49B
$13.3K ﹤0.01%
100
-3
-3% -$379
TMDX icon
159
Transmedics
TMDX
$3.12B
$13.3K ﹤0.01%
200
NFJ
160
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.46B
$12.5K ﹤0.01%
+825
New +$11.9K
AIPO
161
Defiance AI & Power Infrastructure ETF
AIPO
$942M
$12.4K ﹤0.01%
+370
New +$11.5K
SII
162
Sprott
SII
$3.33B
$12.4K ﹤0.01%
110
ADM icon
163
Archer Daniels Midland
ADM
$40.8B
$12K ﹤0.01%
158
+1
+0.6% +$76
DTM icon
164
DT Midstream
DTM
$13.2B
$12K ﹤0.01%
82
SPCX
165
SpaceX
SPCX
$1.95T
$12K ﹤0.01%
+70
New +$11.9K
APO icon
166
Apollo Global Management
APO
$78.9B
$11.8K ﹤0.01%
100
NTR icon
167
Nutrien
NTR
$37.9B
$11.8K ﹤0.01%
187
MCHI icon
168
iShares MSCI China ETF
MCHI
$6.33B
$11.6K ﹤0.01%
228
+1
+0.4% +$56
IWV icon
169
iShares Russell 3000 ETF
IWV
$20.3B
$11.4K ﹤0.01%
27
STK
170
Columbia Seligman Premium Technology Growth Fund
STK
$930M
$11.3K ﹤0.01%
+210
New +$10.4K
SYK icon
171
Stryker
SYK
$116B
$11K ﹤0.01%
35
FMS icon
172
Fresenius Medical Care
FMS
$12.1B
$10.8K ﹤0.01%
478
ESS icon
173
Essex Property Trust
ESS
$17.9B
$10.8K ﹤0.01%
37
EXG icon
174
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.06B
$10.7K ﹤0.01%
+1,092
New +$10.2K
AADR icon
175
AdvisorShares Dorsey Wright ADR ETF
AADR
$39.4M
$10.7K ﹤0.01%
+130
New +$11K

Similar funds

MB, Levis & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, MB, Levis & Associates held 266 positions worth $271M, up 13% from $240M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

MB, Levis & Associates deployed $15.6M of net new capital in Q2 2026, opening 32 new positions and adding to 93 existing holdings. Its largest new stake was iShares iBonds Dec 2036 Term Corporate ETF: 551,113 shares worth $13.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 77% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares iBonds Dec 2031 Term Corporate ETF, an estimated $13.7M trimmed.

  • MB, Levis & Associates's largest Q2 2026 buy was iShares iBonds Dec 2036 Term Corporate ETF: 551,113 shares worth $13.9M.
  • MB, Levis & Associates added most to Vanguard Morningstar Small-Cap ETF in Q2 2026, an estimated $11.9M increase.
  • MB, Levis & Associates's biggest Q2 2026 reduction was iShares iBonds Dec 2031 Term Corporate ETF, cutting an estimated $13.7M.
  • MB, Levis & Associates fully exited Sealed Air in Q2 2026, selling an estimated $11.9K.
  • MB, Levis & Associates's ten largest holdings make up 59% of its $271M portfolio in Q2 2026.
  • MB, Levis & Associates opened 32 new positions and closed 12 in Q2 2026.
  • MB, Levis & Associates's portfolio value rose 13% quarter-over-quarter to $271M.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.